Kenvue Inc. Common Stock vs MaxLinear Inc. Common Stock — how do they compare? Kenvue Inc. Common Stock trades at $17.69 (market cap $34.06B), while MaxLinear Inc. Common Stock trades at $96.49 (market cap $8.50B). The key difference: Kenvue Inc. Common Stock is far larger — about 4× MaxLinear Inc. Common Stock's market cap, and Kenvue Inc. Common Stock pays a 4.74% dividend while MaxLinear Inc. Common Stock pays none. Which is the better fit depends on your goals.
| KVUE | MXL | |
|---|---|---|
Market Cap | $34.06B | $8.50B |
Volume | 23,267,228 | 4,008,439 |
Sector | Consumer Staples | Technology |
52-Week High | $19.83 | $128.03 |
52-Week Low | $14.11 | $13.05 |
Enterprise Value | $41.56B | $8.58B |
Dividend Yield | 4.74% | — |
Typical Hold Time | — | 1 Days |
Trailing returns across standard periods
Latest headlines on both assets
Kenvue is a consumer health company that markets personal care, self-care, and skin health products. Its brands include Tylenol, Listerine, Neutrogena, Johnson’s, BAND-AID Brand, Aveeno, and Zyrtec.
Read more on KVUE →MaxLinear develops analog and mixed-signal semiconductors for connectivity, communications, industrial, and data center applications.
Read more on MXL →